VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
SBRASabra Health Care REIT, Inc.
$18.27$4.6B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSBRAEarnings History

SBRA logoSabra Health Care REIT, Inc. (SBRA) Earnings History

Turnaround

16 years of earnings data (2010–2025) · Recovering earnings after a multi-year decline

TTM Net Income
$156M
● Profitable
TTM EPS (Diluted)
$0.61
Per share, diluted
YoY EPS Growth
+18.5%
Strong
Net Margin
20.1%
After-tax profitability
EPS Growth Rate (CAGR)
1Y+18.5%
3YN/A
5Y-0.9%
10Y-5.4%
Operating Margin34.1%
Gross Margin65.0%
Return on Equity5.6%
Return on Assets2.9%
Record Annual Net Income$279MFY2018
Record Quarterly EPS$1.08Q2 2018
Consecutive Profitable Years3years
Q1 2026
Net Income$41M
EPS (Diluted)$0.16
YoY Growth+18.5%Strong
QoQ Growth+50.2%Excellent

Loading earnings history...

Sabra Health Care REIT, Inc. (SBRA) Earnings Overview

As of June 23, 2026, Sabra Health Care REIT, Inc. (SBRA) reported trailing twelve-month net income of $156M, reflecting +18.5% year-over-year growth. The company earned $0.61 per diluted share over the past four quarters, with a net profit margin of 20.1%.

Looking at the long-term picture, SBRA's 5-year EPS compound annual growth rate (CAGR) stands at -0.9%, signaling declining earnings. The company achieved its highest annual net income of $279M in fiscal 2018.

Sabra Health Care REIT, Inc. maintains industry-leading profitability with a gross margin of 65.0%, operating margin of 34.1%, and net margin of 20.1%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →

Compared to peers including WELL ($1.43B net income, 8.8% margin), VTR ($260M net income, 4.3% margin), OHI ($632M net income, 49.3% margin), SBRA has outperformed on profitability metrics. Compare SBRA vs WELL →

SBRA Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
SBRA logoSBRACurrent
$156M$0.6120.1%5.6%+18.5%—
WELL logoWELL
$1.4B$1.978.8%2.5%-11.5%
VTR logoVTR
$260M$0.544.3%2.1%+184.2%
OHI logoOHI
$632M$2.0149.3%11.6%+25.2%
LTC logoLTC
$121M$2.4744.9%10.7%+23.5%
CTRE logoCTRE
$335M$1.5067.3%9.2%+96.3%
Best in group
Lowest in group

SBRA Historical Earnings Data (2010–2025)

16 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025$156M+22.8%$264M$0.6420.1%34.1%
2024$127M+821.1%$257M$0.5418.0%36.5%
2023$14M+117.7%$222M$0.062.1%34.2%
2022-$78M+31.5%$235M$-0.34-12.4%37.6%
2021-$113M-181.8%$211M$-0.52-19.9%37.0%
2020$138M+100.6%$0$0.6723.1%0.0%
2019$69M-75.3%$528M$0.3710.3%79.0%
2018$279M+76.2%$307M$1.5644.8%49.2%
2017$158M+125.4%$224M$1.4039.0%55.3%
2016$70M-11.5%$161M$0.9227.0%61.8%
2015$79M+69.1%$137M$1.1133.2%57.1%
2014$47M+39.3%$111M$0.7825.6%60.4%
2013$34M+72.8%$85M$0.6825.0%63.1%
2012$20M+51.9%$57M$0.5218.9%55.1%
2011$13M+74.1%$43M$0.4315.2%51.2%
2010$7M-$200,000$0.2983.8%2.3%

Download Data

Export SBRA earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

16+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SBRA — Frequently Asked Questions

Quick answers to the most common questions about buying SBRA stock.

What is SBRA earnings per share (EPS)?

SBRA trailing twelve-month (TTM) diluted EPS is $0.61, reflecting +18.5% year-over-year growth. The 5-year EPS CAGR is -0.9%. Complete EPS history from 2010 to 2025 is available in the table on this page.

What is Sabra Health Care REIT, Inc.'s net income?

Sabra Health Care REIT, Inc. (SBRA) trailing twelve-month net income is $156M as of 2025. Earnings grew +18.5% year-over-year. Sabra Health Care REIT, Inc. has been profitable for 3 consecutive years.

Is SBRA profitable?

Yes, SBRA is profitable with a TTM net income of $156M and a net profit margin of +20.1%. Sabra Health Care REIT, Inc. has generated profits for 3 consecutive years.

What is SBRA's earnings growth rate?

SBRA compound annual EPS growth rates (CAGR): 1-Year: +18.5%, 3-Year: N/A, 5-Year: -0.9%, 10-Year: -5.4%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2010 to 2025.

What are SBRA's profit margins?

Sabra Health Care REIT, Inc. net profit margin is +20.1%, operating margin is +34.1%, and gross margin is +65.0%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +5.6%.

Is SBRA growing earnings?

Yes, SBRA earnings are accelerating — EPS growth of +18.5% exceeds the 5-year CAGR of -0.9%. TTM net income reached $156M. Earnings momentum is strengthening.

What was SBRA's best earnings year?

Sabra Health Care REIT, Inc.'s highest annual net income on record is $279M, achieved in fiscal year 2018. Earnings history on this page spans 2010 to 2025 and includes all annual and quarterly figures.

What were SBRA's earnings last quarter?

SBRA's most recent reported quarter was Q1 2026. Net income was $41M with diluted EPS of $0.16. For a full breakdown of all quarters, see the quarterly earnings table on this page.

SBRA Earnings Over Time (2010–2025)

Net income & EPS — annual and quarterly view